RT Journal Article
SR Electronic
T1 TMS target comparison identifies motor network reorganization associated with behavioral improvement in writer’s cramp dystonia: A randomized, double-blind, Sham-controlled clinical trial
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.30.24314652
DO 10.1101/2024.09.30.24314652
A1 Bukhari-Parlakturk, Noreen
A1 Mulcahey, Patrick J.
A1 Lutz, Michael W.
A1 Ghazi, Rabia
A1 Huang, Ziping
A1 Dannhauer, Moritz
A1 Termsarasab, Pichet
A1 Scott, Burton
A1 Simsek, Zeynep B.
A1 Groves, Skylar
A1 Lipp, Mikaela
A1 Fei, Michael
A1 Tran, Tiffany K.
A1 Wood, Eleanor
A1 Beynel, Lysianne
A1 Petty, Chris
A1 Voyvodic, James T.
A1 Appelbaum, Lawrence G.
A1 Al-Khalidi, Hussein R.
A1 Davis, Simon W.
A1 Michael, Andrew M.
A1 Peterchev, Angel V.
A1 Calakos, Nicole
YR 2024
UL http://medrxiv.org/content/early/2024/10/01/2024.09.30.24314652.abstract
AB Background Writer’s cramp (WC) dystonia is an involuntary movement disorder with distributed abnormalities in the brain’s motor network. Prior studies established the potential for repetitive transcranial magnetic stimulation (rTMS) to either premotor cortex (PMC) or primary somatosensory cortex (PSC) to modify symptoms. However, clinical effects have been modest with limited understanding of the neural mechanisms hindering therapeutic advancement of this promising approach.Objective This study aimed to understand the motor network effects of rTMS in WC that correspond with behavioral efficacy. We hypothesized that behavioral efficacy is associated with modulation of cortical and subcortical regions of the motor network.Methods In a double-blind, cross-over design, twelve WC participants underwent weekly 10 Hz rTMS in one of three conditions (Sham-TMS, PSC-TMS, PMC-TMS) while engaged in a writing task to activate dystonic movements and measure writing fluency. Brain connectivity was evaluated using task-based fMRI after each TMS session.Results 10 Hz rTMS to PSC, but not PMC, significantly improved writing dysfluency. PSC-TMS also significantly weakened cortico-basal ganglia, cortico-cerebellum, and intra-cerebellum functional connectivity (FC), and strengthened striatal connectivity relative to Sham. Increased PSC BOLD activity was associated with reduced dysfluent writing behavior.Conclusions 10 Hz rTMS to PSC improved writing dysfluency by redistributing motor network connectivity and strengthening somatosensory-parietal connectivity. A key signature for effective stimulation at PSC and improvement in writing dysfluency may be strengthening of intra-cortical connectivity between primary somatosensory and superior parietal cortices. These findings offer mechanistic hypotheses to advance the therapeutic application of TMS for dystonia.Highlights10 Hz repetitive TMS to somatosensory cortex reduces writing dysfluency in dystoniaIncreased somatosensory cortex activity correlates with reduced writing dysfluencyIn untreated dystonia, writing dysfluency correlates with cerebellar connectivity.10 Hz rTMS to somatosensory cortex induces reorganization of the motor networkSomatosensory-parietal connectivity may be a key signature for effective TMSCompeting Interest StatementNBP serves as a member of the DMRF Medical and Scientific Advisory Council. AVP serves on the editorial board of the Brain Stimulation journal. AVP is an inventor of patents and patent applications on transcranial magnetic stimulation technology and has received patent royalties and consulting fees from Rogue Research; equity options, scientific advisory board membership, and consulting fees from Ampa Health; equity options and consulting fees from Magnetic Tides; consulting fees from Soterix Medical; equipment loans from MagVenture; and research funding from Motif. SWD has received consulting fees from Neuronetics. None of these sources played a role in the design, collection, analysis, interpretation of the data, or in the decision to submit the manuscript for publication. PJM, MWL, RG, ZH, MD, ZBS, SG, ML, TKT, EW, LB, CP, JTV, LGA, HRA, AMM and NC report no relevant financial disclosures.Clinical TrialNCT06422104Funding StatementThis work was supported by grants to NBP from Dystonia Medical Research Foundation (Clinical Fellowship Training Program), Doris Duke Charitable Foundation (Fund to Retain Clinician Scientists), American Academy of Neurology (career development award) and NIH NCATS (1KL2TR002554). NBP was also supported by a career development award from the Dystonia Coalition (NS065701, TR001456, NS116025) which is part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported by the Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS), and the National Institute of Neurological Diseases and Stroke (NINDS). AVP's contributions were supported in part by the National Institutes of Health (R01MH128422, R01NS117405). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Duke Health Institutional Review Board gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data and codes are available upon reasonable request to the authors.PSCprimary somatosensory cortexPMCmotor and premotor cortexWCwriter’s cramp dystonia